A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)
Status:
Not yet recruiting
Trial end date:
2024-09-26
Target enrollment:
Participant gender:
Summary
This is a study evaluating the effect of fenebrutinib on brain MRI in participants with RMS.
The safety and pharmacokinetics of fenebrutinib will also be evaluated. Participants will be
randomized to receive either fenebrutinib or placebo.